Cargando…

Establishment of primary human breast cancer cell lines using “pulsed hypoxia” method and development of metastatic tumor model in immunodeficient mice

BACKGROUND: Among breast cancer (BC) patients the outcomes of anticancer therapy vary dramatically due to the highly heterogeneous molecular characteristics of BC. Therefore, an extended panel of BC cell lines are required for in vitro and in vivo studies to find out new characteristic of carcinogen...

Descripción completa

Detalles Bibliográficos
Autores principales: Nushtaeva, Anna A., Karpushina, Anastasia A., Ermakov, Mikhail S., Gulyaeva, Ludmila F., Gerasimov, Alexey V., Sidorov, Sergey V., Gayner, Tatyana A., Yunusova, Anastasia Y., Tkachenko, Anastasia V., Richter, Vladimir A., Koval, Olga A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394017/
https://www.ncbi.nlm.nih.gov/pubmed/30858763
http://dx.doi.org/10.1186/s12935-019-0766-5
_version_ 1783398806324248576
author Nushtaeva, Anna A.
Karpushina, Anastasia A.
Ermakov, Mikhail S.
Gulyaeva, Ludmila F.
Gerasimov, Alexey V.
Sidorov, Sergey V.
Gayner, Tatyana A.
Yunusova, Anastasia Y.
Tkachenko, Anastasia V.
Richter, Vladimir A.
Koval, Olga A.
author_facet Nushtaeva, Anna A.
Karpushina, Anastasia A.
Ermakov, Mikhail S.
Gulyaeva, Ludmila F.
Gerasimov, Alexey V.
Sidorov, Sergey V.
Gayner, Tatyana A.
Yunusova, Anastasia Y.
Tkachenko, Anastasia V.
Richter, Vladimir A.
Koval, Olga A.
author_sort Nushtaeva, Anna A.
collection PubMed
description BACKGROUND: Among breast cancer (BC) patients the outcomes of anticancer therapy vary dramatically due to the highly heterogeneous molecular characteristics of BC. Therefore, an extended panel of BC cell lines are required for in vitro and in vivo studies to find out new characteristic of carcinogenesis and metastasis. The purpose of this study was to develop patient-derived BC cell cultures and metastatic tumor models representing a tool for personal therapy and translational research. METHODS: Breast cancer cells were prepared by optimizing technique from tumor samples. We used real-time RT-PCR, flow cytometry, western blotting, cytotoxicity assay, karyotyping and fluorescent and electron microscopy analyses to characterize the established cell lines. BC xenografts in scid mice were used for in vivo tumorigenicity studies. RESULTS: The technique of preparing primary cells was optimized and this resulted in a high output of viable and active proliferated cells of nine patient-derived breast cancer cell lines and one breast non-malignant cell line. High E-cadherine and EpCAM expression correlated positively with epithelial phenotype while high expression of N-cadherine and Vimentin were shown in cells with mesenchymal phenotype. All mesenchymal-like cell lines were high HER3-positive—up to 90%. More interesting than that, is that two cell lines under specific culturing conditions (pulsed hypoxia and conditioned media) progressively transformed from mesenchymal to epithelial phenotypes displaying the expression of respective molecular markers proving that the mesenchymal-to-epithelial transition occurred. Becoming epithelial, these cells have lost HER3 and decreased HER2 membrane receptors. Three of the established epithelial cancer cell lines were tumorigenic in SCID mice and the generated tumors exhibited lobules-like structures. Ultrastructure analysis revealed low-differentiate phenotype of tumorigenic cell lines. These cells were in near-triploid range with multiple chromosome rearrangements. Tumorigenic BrCCh4e cells, originated from the patient of four-course chemotherapy, initiated metastasis when they were grafted subcutaneous with colonization of mediastinum lymph nodes. CONCLUSIONS: The developed BC cells metastasizing to mediastinum lymph nodes are a relevant model for downstream applications. Moreover, our findings demonstrate that pulsed hypoxia induces transformation of primary fibroblastoid breast cancer cells to epithelial-like cells and both of these cultures—induced and original—don’t show tumor initiating capacity. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12935-019-0766-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6394017
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63940172019-03-11 Establishment of primary human breast cancer cell lines using “pulsed hypoxia” method and development of metastatic tumor model in immunodeficient mice Nushtaeva, Anna A. Karpushina, Anastasia A. Ermakov, Mikhail S. Gulyaeva, Ludmila F. Gerasimov, Alexey V. Sidorov, Sergey V. Gayner, Tatyana A. Yunusova, Anastasia Y. Tkachenko, Anastasia V. Richter, Vladimir A. Koval, Olga A. Cancer Cell Int Primary Research BACKGROUND: Among breast cancer (BC) patients the outcomes of anticancer therapy vary dramatically due to the highly heterogeneous molecular characteristics of BC. Therefore, an extended panel of BC cell lines are required for in vitro and in vivo studies to find out new characteristic of carcinogenesis and metastasis. The purpose of this study was to develop patient-derived BC cell cultures and metastatic tumor models representing a tool for personal therapy and translational research. METHODS: Breast cancer cells were prepared by optimizing technique from tumor samples. We used real-time RT-PCR, flow cytometry, western blotting, cytotoxicity assay, karyotyping and fluorescent and electron microscopy analyses to characterize the established cell lines. BC xenografts in scid mice were used for in vivo tumorigenicity studies. RESULTS: The technique of preparing primary cells was optimized and this resulted in a high output of viable and active proliferated cells of nine patient-derived breast cancer cell lines and one breast non-malignant cell line. High E-cadherine and EpCAM expression correlated positively with epithelial phenotype while high expression of N-cadherine and Vimentin were shown in cells with mesenchymal phenotype. All mesenchymal-like cell lines were high HER3-positive—up to 90%. More interesting than that, is that two cell lines under specific culturing conditions (pulsed hypoxia and conditioned media) progressively transformed from mesenchymal to epithelial phenotypes displaying the expression of respective molecular markers proving that the mesenchymal-to-epithelial transition occurred. Becoming epithelial, these cells have lost HER3 and decreased HER2 membrane receptors. Three of the established epithelial cancer cell lines were tumorigenic in SCID mice and the generated tumors exhibited lobules-like structures. Ultrastructure analysis revealed low-differentiate phenotype of tumorigenic cell lines. These cells were in near-triploid range with multiple chromosome rearrangements. Tumorigenic BrCCh4e cells, originated from the patient of four-course chemotherapy, initiated metastasis when they were grafted subcutaneous with colonization of mediastinum lymph nodes. CONCLUSIONS: The developed BC cells metastasizing to mediastinum lymph nodes are a relevant model for downstream applications. Moreover, our findings demonstrate that pulsed hypoxia induces transformation of primary fibroblastoid breast cancer cells to epithelial-like cells and both of these cultures—induced and original—don’t show tumor initiating capacity. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12935-019-0766-5) contains supplementary material, which is available to authorized users. BioMed Central 2019-02-28 /pmc/articles/PMC6394017/ /pubmed/30858763 http://dx.doi.org/10.1186/s12935-019-0766-5 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Primary Research
Nushtaeva, Anna A.
Karpushina, Anastasia A.
Ermakov, Mikhail S.
Gulyaeva, Ludmila F.
Gerasimov, Alexey V.
Sidorov, Sergey V.
Gayner, Tatyana A.
Yunusova, Anastasia Y.
Tkachenko, Anastasia V.
Richter, Vladimir A.
Koval, Olga A.
Establishment of primary human breast cancer cell lines using “pulsed hypoxia” method and development of metastatic tumor model in immunodeficient mice
title Establishment of primary human breast cancer cell lines using “pulsed hypoxia” method and development of metastatic tumor model in immunodeficient mice
title_full Establishment of primary human breast cancer cell lines using “pulsed hypoxia” method and development of metastatic tumor model in immunodeficient mice
title_fullStr Establishment of primary human breast cancer cell lines using “pulsed hypoxia” method and development of metastatic tumor model in immunodeficient mice
title_full_unstemmed Establishment of primary human breast cancer cell lines using “pulsed hypoxia” method and development of metastatic tumor model in immunodeficient mice
title_short Establishment of primary human breast cancer cell lines using “pulsed hypoxia” method and development of metastatic tumor model in immunodeficient mice
title_sort establishment of primary human breast cancer cell lines using “pulsed hypoxia” method and development of metastatic tumor model in immunodeficient mice
topic Primary Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394017/
https://www.ncbi.nlm.nih.gov/pubmed/30858763
http://dx.doi.org/10.1186/s12935-019-0766-5
work_keys_str_mv AT nushtaevaannaa establishmentofprimaryhumanbreastcancercelllinesusingpulsedhypoxiamethodanddevelopmentofmetastatictumormodelinimmunodeficientmice
AT karpushinaanastasiaa establishmentofprimaryhumanbreastcancercelllinesusingpulsedhypoxiamethodanddevelopmentofmetastatictumormodelinimmunodeficientmice
AT ermakovmikhails establishmentofprimaryhumanbreastcancercelllinesusingpulsedhypoxiamethodanddevelopmentofmetastatictumormodelinimmunodeficientmice
AT gulyaevaludmilaf establishmentofprimaryhumanbreastcancercelllinesusingpulsedhypoxiamethodanddevelopmentofmetastatictumormodelinimmunodeficientmice
AT gerasimovalexeyv establishmentofprimaryhumanbreastcancercelllinesusingpulsedhypoxiamethodanddevelopmentofmetastatictumormodelinimmunodeficientmice
AT sidorovsergeyv establishmentofprimaryhumanbreastcancercelllinesusingpulsedhypoxiamethodanddevelopmentofmetastatictumormodelinimmunodeficientmice
AT gaynertatyanaa establishmentofprimaryhumanbreastcancercelllinesusingpulsedhypoxiamethodanddevelopmentofmetastatictumormodelinimmunodeficientmice
AT yunusovaanastasiay establishmentofprimaryhumanbreastcancercelllinesusingpulsedhypoxiamethodanddevelopmentofmetastatictumormodelinimmunodeficientmice
AT tkachenkoanastasiav establishmentofprimaryhumanbreastcancercelllinesusingpulsedhypoxiamethodanddevelopmentofmetastatictumormodelinimmunodeficientmice
AT richtervladimira establishmentofprimaryhumanbreastcancercelllinesusingpulsedhypoxiamethodanddevelopmentofmetastatictumormodelinimmunodeficientmice
AT kovalolgaa establishmentofprimaryhumanbreastcancercelllinesusingpulsedhypoxiamethodanddevelopmentofmetastatictumormodelinimmunodeficientmice